objectiveshypothesi
measur
popul
fungi
home
sinus
chronic
rhinosinus
cr
noncr
patient
studi
design
singleblind
crosssect
studi
method
popul
fungi
measur
sinu
sampl
home
vacuum
cleaner
dust
cr
n
noncr
patient
n
use
quantit
polymeras
chain
reaction
etest
strip
contain
amphotericin
b
anidulafungin
caspofungin
fluconazol
voriconazol
use
test
suscept
seven
potenti
relev
fungi
result
seven
fungi
alternaria
alternata
cladosporium
cladosporioid
type
cladosporium
herbarum
penicillium
brevicompactum
penicillium
crustosum
penicillium
chrysogenum
type
discov
high
concentr
cr
patient
vitro
antifung
suscept
test
seven
fungi
demonstr
speci
specif
sensit
four
cr
patient
mark
elev
fungal
popul
sinu
sampl
underw
endoscop
sinu
surgeri
surgic
treatment
fungal
popul
reduc
sever
order
magnitud
conclus
seven
fungi
found
high
concentr
sinus
cr
patient
one
five
common
antifung
agent
could
control
seven
fungi
base
vitro
test
chronic
rhinosinus
cr
one
common
diseas
adult
unit
state
result
million
offic
visit
physician
year
current
etiolog
cr
remain
elus
limit
treatment
option
patient
role
fungi
cr
remain
controversi
mani
differ
experiment
detail
ad
controversi
includ
multipl
method
sampl
collect
anatom
differ
sampl
locat
vari
antifung
agent
test
variabl
method
administr
concentr
antifung
agent
one
observ
research
agre
fungi
cultur
nasal
sampl
peopl
ill
cultur
provid
quantit
inform
popul
fungu
research
us
environment
protect
agenc
develop
dnabas
method
fungal
analysi
specif
quantit
method
use
quantifi
popul
common
widespread
fungi
sinu
patient
home
dust
sampl
fungi
group
fungi
indic
water
damag
group
speci
often
found
home
even
without
water
damag
primarili
come
outdoor
homeexposur
estim
fungi
base
scale
call
environment
rel
moldi
index
ermi
use
mathemat
formula
convert
concentr
fungi
singl
number
ermi
valu
ermi
valu
describ
water
damag
fungal
growth
home
base
comparison
random
nation
sampl
home
aim
studi
measur
compar
quantiti
fungi
patient
sinus
vacuum
cleaner
bag
dust
sampl
home
individu
addit
antifung
suscept
seven
potenti
relev
fungi
evalu
use
etest
antifung
strip
protocol
studi
approv
committe
human
research
patient
recruit
studi
routin
care
appoint
outpati
clinic
practic
devot
rhinolog
gener
otolaryngolog
subject
recruit
studi
two
broad
group
patient
cr
control
subject
without
cr
patient
cr
histori
chronic
sinus
symptom
month
patient
nasal
endoscop
evid
cr
nasal
polyposi
physic
examin
patient
sinus
evid
cr
comput
tomographi
examin
patient
therefor
met
criteria
defin
diagnosi
chromic
rhinosinus
base
american
academi
otolaryngologyhead
neck
surgeri
publish
guidelin
well
consensu
recommend
control
subject
undergo
nasal
endoscopi
part
gener
otolaryngolog
examin
complaint
pertain
acut
rhinosinus
cr
patient
control
group
clinic
complaint
warrant
fiberopt
examin
nose
throat
nasal
endoscopi
show
evid
sinu
diseas
four
patient
underw
surgeri
cr
volunt
sinus
resampl
month
year
first
sampl
patient
given
phenylephrin
aerosol
spray
tetracain
aerosol
spray
allow
comfort
initi
endoscop
examin
interdent
brush
acclean
henri
schein
inc
melvil
ny
steam
steril
use
specimen
collect
brush
sampl
collect
three
physician
list
first
three
author
hopkin
rod
attach
camera
light
sourc
use
guid
brush
middl
meatu
direct
visual
swab
middl
meatu
mucosa
remov
mucou
area
brush
place
ml
conic
bottom
screw
cap
tube
pgc
scientif
gaithersburg
md
specimen
refriger
transport
laboratori
ice
pack
patient
ask
submit
vacuum
cleaner
bag
vacuum
cleaner
content
ziploc
bag
patient
confirm
vacuum
cleaner
use
home
sampl
repres
home
environ
also
transport
laboratori
analysi
brush
sampl
receiv
laboratori
g
mm
zirconiasilica
bead
generit
north
brunswick
nj
ad
tube
dust
retriev
patient
vacuum
cleaner
siev
size
nylon
mesh
screen
gilson
lewi
center
oh
total
mg
siev
dust
place
steril
screwcap
extract
tube
load
g
mm
zirconiasilica
bead
brush
dust
sampl
spike
conidia
geotrichum
candidum
extern
refer
extract
tube
shaken
bead
beater
biospec
product
bartlesvil
ok
minut
dna
purifi
use
dnaez
extract
kit
generit
method
assay
report
previous
perform
quantit
polymeras
chain
reaction
qpcr
briefli
standard
reaction
assay
contain
univers
master
mix
appli
biosystem
inc
foster
citi
ca
mixtur
forward
revers
primer
lm
nm
taqman
probe
appli
biosystem
inc
mgml
fraction
v
bovin
serum
albumin
sigma
chemic
st
loui
mo
dnafre
water
cepheid
sunnyval
ca
mix
ad
dna
extract
sampl
primer
probe
sequenc
use
assay
well
known
speci
compris
assay
group
websit
http
wwwepagovnerlcwwwmoldtechhtm
primer
probe
synthes
commerci
appli
biosystem
inc
reaction
perform
thermal
cycl
condit
consist
minut
c
minut
c
follow
cycl
second
c
templat
denatur
minut
c
probe
primer
anneal
primer
extens
cycl
threshold
determin
automat
perform
instrument
use
default
paramet
assay
target
speci
intern
refer
g
candidum
perform
separ
tube
plate
format
antifung
suscept
penicillium
brevicompactum
penicillium
crustosum
penicillium
chrysogenum
type
alternaria
alternata
cladosporium
cladosporioid
type
cladosporium
herbarum
evalu
use
etest
strip
biomerieux
marci
letoil
franc
accord
manufactur
instruct
conidi
suspens
prepar
steril
distil
water
adjust
conidiaml
total
ml
conidia
suspens
spread
evenli
onto
surfac
plate
rpmi
roswel
park
memori
institut
nmorpholino
propanesulfon
acid
mop
glucos
remel
lenexa
ks
use
glass
spreader
asept
techniqu
inocul
surfac
allow
dri
complet
etest
strip
contain
amphotericin
b
anidulafungin
caspofungin
fluconazol
voriconazol
appli
plate
incub
c
hour
confluent
lawn
growth
clearli
visibl
photograph
minimum
inhibitori
concentr
read
lowest
drug
concentr
border
ellipt
inhibit
zone
intercept
scale
etest
antifung
strip
analysi
perform
triplic
averag
ermi
valu
cr
patient
home
significantli
differ
averag
ermi
valu
found
noncr
patient
home
respect
data
shown
rate
detect
four
speci
c
cladosporioid
type
c
herbarum
aureobasidium
pullulan
significantli
correl
fischer
exact
test
home
dust
brush
sampl
tabl
howev
mani
fungi
either
never
detect
detect
brush
sampl
rest
fungi
rate
detect
similar
brush
sampl
cr
noncr
patient
tabl
wilcoxon
rank
sum
analysi
averag
concentr
fungi
cr
versu
noncr
bush
sampl
suggest
two
speci
alternata
c
cladosporioid
type
statist
higher
concentr
p
howev
differ
significantli
differ
holm
test
appli
correct
multipl
comparison
five
addit
fungi
concentr
averag
cr
patient
brush
sampl
time
higher
averag
noncr
brush
sampl
tabl
ii
base
find
specif
fungi
occur
much
higher
concentr
cr
patient
cr
patient
subdivid
two
categori
patient
one
seven
fungi
time
concentr
averag
noncr
patient
brush
sampl
place
categori
call
highfung
cr
n
remain
patient
design
lowfung
cr
n
wilcoxon
rank
sum
analysi
averag
concentr
fungi
show
seven
fungi
significantli
higher
concentr
p
highfung
cr
versu
lowcr
brush
sampl
tabl
iii
howev
four
fungi
p
crustosum
p
chrysogenum
type
c
cladosporioid
type
c
herbarum
significantli
differ
holm
correct
appli
adjust
multipl
comparison
four
highfung
cr
patient
underw
surgeri
studi
period
four
surgic
case
revis
sinu
surgic
procedur
patient
mani
year
chronic
sinus
sign
symptom
refractori
salin
irrig
antibiot
therapi
topic
oral
corticosteroid
treatment
small
rate
detect
fungu
cr
noncr
brush
sampl
given
p
valu
signific
associ
specif
mold
dust
brush
sampl
cohort
multipl
year
sinu
treatment
yet
persist
chronic
rhinosinus
postop
brush
sampl
obtain
followup
sampl
show
much
lower
fungal
concentr
speci
previous
high
tabl
iv
howev
fungi
elimin
surgeri
fact
speci
previous
detect
detect
low
concentr
exampl
wallemia
sebi
detect
cr
patient
aspegillu
niger
cr
patient
paecilomyc
variotii
cr
patient
tabl
lv
antifung
suscept
test
perform
seven
fungi
interest
alternata
c
cladosporioid
type
c
herbarum
p
brevicompactum
p
crustosum
p
chrysogenum
type
use
etest
strip
contain
concentr
gradient
amphotericin
b
anidulafungin
caspofungin
fluconazol
voriconazol
result
shown
figur
amphotericin
b
effect
c
cladosporioid
type
less
effect
fungi
effect
c
herbarum
anidulafungin
effect
fungi
expect
c
herbarum
unaffect
caspofungin
moder
effect
fungi
fluconazol
effect
fungi
moder
effect
c
cladosporioid
type
alternata
voriconazol
effect
c
cladosporioid
type
moder
effect
fungi
test
fungal
exposur
base
ermi
valu
home
similar
cr
noncr
patient
addit
averag
concentr
mani
speci
similar
dust
sampl
cr
noncr
patient
taken
togeth
result
suggest
exposur
fungi
appear
similar
home
environ
howev
differ
base
exposur
environ
rule
rate
detect
fungi
dust
sampl
gener
higher
rate
detect
brush
sampl
tabl
mani
possibl
reason
differ
detect
rate
differ
might
function
sampl
type
ie
brush
vs
mg
dust
variat
inhal
clearanc
rate
might
creat
differ
hypothesi
differ
might
rest
abil
speci
colon
sinus
peopl
cr
patient
one
seven
fungi
detect
high
concentr
rel
sampl
find
suggest
popul
cr
patient
may
divid
two
subgroup
highor
lowfung
cr
patient
concentr
one
seven
speci
least
greater
noncr
patient
cr
patient
place
highfung
cr
categori
disproportion
high
concentr
certain
fungi
subpopul
cr
patient
sinu
sampl
support
hypothesi
specif
fungi
abil
grow
amplifi
sinus
suscept
peopl
surgic
alter
sinu
environ
four
highfung
cr
patient
may
explain
reduct
fungal
popul
mani
seven
fungi
gener
outdoor
sourc
like
plant
soil
therefor
call
group
avoid
would
nearli
imposs
therefor
treatment
antifung
agent
might
altern
approach
control
fungal
growth
cr
patient
previou
studi
use
antifung
agent
treatment
cr
report
benefici
effect
other
littl
none
data
provid
possibl
explan
regard
variabl
result
clinic
trial
evalu
antifung
agent
case
cr
associ
fungi
benefit
fraction
might
lost
larger
popul
cr
patient
also
possibl
antifung
treatment
regim
use
trial
inadequ
control
fungal
growth
fungi
invas
dissemin
tissu
typic
fungal
pathogen
eg
aspergillu
fumigatu
amplif
sinus
colon
may
present
difficult
target
penetr
antifung
agent
antifung
agent
test
vitro
abl
suppress
growth
potenti
relev
fungi
amphotericn
b
use
mani
clinic
trial
cr
measur
effect
growth
c
herbarum
fluconozol
gener
least
effect
agent
inhibit
growth
publish
clinic
trial
also
fail
monitor
treatment
determin
concentr
fungi
sinus
control
result
suggest
futur
clinic
trial
screen
highfung
cr
patient
combin
multipl
antifung
agent
evalu
whether
treatment
actual
reduc
fungal
popul
studi
number
limit
first
fungi
monitor
perhap
hundr
potenti
relev
fungi
addit
microorgan
promin
bacteria
immun
dysfunct
also
implic
etiolog
cr
studi
evalu
either
factor
final
data
led
divis
cr
patient
highand
lowfung
categori
diminish
power
statist
analysi
result
correct
multipl
comparison
speci
data
fail
statist
signific
howev
result
provid
guidanc
futur
studi
identif
pathophysiolog
cr
may
complic
presenc
multipl
distinct
etiolog
fungi
involv
case
qpcr
analysi
may
help
identifi
role
specif
fungi
portion
cr
patient
result
also
suggest
target
approach
treatment
select
patient
multipl
antifung
agent
might
desir
fig
minimum
inhibitori
concentr
etest
antifung
strip
amphotericin
b
open
bar
first
bar
anidulafungin
dark
hatch
second
bar
caspofungin
black
third
bar
fluconazol
gray
forth
bar
voriconazol
dot
fifth
bar
seven
fungi
associ
case
chronic
rhinosinus
asterisk
indic
fungu
unaffect
highest
agent
concentr
etest
strip
ie
amphotericin
b
anidulafungin
caspofungin
lgml
fluconazol
voriconazol
lgml
